Moderna Reaps $5.9 Billion From Its Vaccine Sales

Stéphane Bancel, the company’s chief executive officer, said Moderna has $21 billion worth of advance purchase agreements for the vaccine.

source https://www.nytimes.com/2022/05/04/world/moderna-covid-vaccine.html